/ Active, not recruiting临床2期 PHASE II CLINICAL TRIAL OF IMMUNOTHERAPY WITH AN ALLOGENEIC B7.1/HLA-A1 TRANSFECTED TUMOR CELL VACCINE (PT 107) IN PATIENTS WITH STAGES IIIB/IV NON-SMALL CELL LUNG CANCER THAT HAVE COMPLETED FIRST LINE CHEMOTHERAPY
100 项与 Pique Therapeutics, Inc. 相关的临床结果
0 项与 Pique Therapeutics, Inc. 相关的专利(医药)
100 项与 Pique Therapeutics, Inc. 相关的药物交易
100 项与 Pique Therapeutics, Inc. 相关的转化医学